Safety of pediatric HIV elimination: the growing population of HIV- and antiretroviral-exposed but uninfected infants
- PMID: 24781352
- PMCID: PMC4004531
- DOI: 10.1371/journal.pmed.1001636
Safety of pediatric HIV elimination: the growing population of HIV- and antiretroviral-exposed but uninfected infants
Abstract
Lynne Mofenson and Heather Watts discuss the context and implications of the study by J. Sibuide and colleagues, which provides a detailed analysis of birth defects in infants with in utero antiretroviral drug exposure in the French Perinatal Cohort. Please see later in the article for the Editors' Summary.
Conflict of interest statement
The authors have declared that no competing interests exist.
Comment on
-
Association between prenatal exposure to antiretroviral therapy and birth defects: an analysis of the French perinatal cohort study (ANRS CO1/CO11).PLoS Med. 2014 Apr 29;11(4):e1001635. doi: 10.1371/journal.pmed.1001635. eCollection 2014 Apr. PLoS Med. 2014. PMID: 24781315 Free PMC article.
References
-
- Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, et al. (2002) Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J AIDS 29: 484–494. - PubMed
-
- The United States President's Emergency Plan for AIDS Relief. PEPFAR Tenth Annual Report To Congress (2014). See URL http://www.pepfar.gov/documents/organization/223065.pdf.
-
- World Health Organization (2013) Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Available: http://www.who.int/hiv/pub/guidelines/arv2013/download/en/index.html - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
